TRVI
Trevi Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$11.01
-0.19 ▼ -1.70%
🌙 3월 13일 4:39 PM ET (한국 3/14 05:39)
$11.01
+0.00 +0.00%
| Index | RUT | P/E | - | EPS (ttm) | -0.37 | Insider Own | 35.79% | Shs Outstand | 0.13B | Perf Week | -17.22% |
| Market Cap | 1.41B | Forward P/E | - | EPS next Y | -34.48% | Insider Trans | - | Shs Float | 0.08B | Perf Month | -0.36% |
| Enterprise Value | 1.22B | PEG | - | EPS next Q | -0.1 | Inst Own | 71.17% | Short Float | 20.42% | Perf Quarter | -22.3% |
| Income | -0.05B | P/S | - | EPS this Y | 22.51% | Inst Trans | 0.78% | Short Ratio | 11.67 | Perf Half Y | 12.92% |
| Sales | 0.00B | P/B | 7.44 | EPS next 5Y | -9.44% | ROA | -34.19% | Short Interest | 16.81M | Perf YTD | -12.06% |
| Book/sh | 1.48 | P/C | 7.24 | EPS past 3/5Y | 31.87% 27.09% | ROE | -36.87% | 52W High | -23.49% ($14.39) | Perf Year | 75.04% |
| Cash/sh | 1.52 | P/FCF | - | Sales past 3/5Y | - | ROIC | -24.1% | 52W Low | 127.01% ($4.85) | Perf 3Y | 488.77% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 15.84% | Gross Margin | - | Volatility(W/M) | 8.62% 6.77% | Perf 5Y | 307.78% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.81 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 21.93 | EPS Q/Q | 37.8% | Profit Margin | - | RSI (14) | 44.11 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 21.93 | Sales Q/Q | - | SMA20 | -4.62% ($11.54) | Beta | 1.02 | Target Price | $21.5 |
| Payout | - | Debt/Eq | 0 | Earnings | 3000000 | SMA50 | -2.05% ($11.24) | Rel Volume | 0.68 | Prev Close | $11.2 |
| Employees | 26 | LT Debt/Eq | 0 | EPS/Sales Surpr. | 18.62% - | SMA200 | 15.25% ($9.55) | Avg Volume(3M) | 1.44M | Price | $11.01 |
| IPO | 2019/5/7 | Option/Short | Yes/Yes | Trades | 10837 | Volume | 984,177 | Change | -1.7% |
뉴스 로딩 중...